Answers are grounded in this paper and cite their sources.
Laboratory validation study demonstrates an eco-friendly RP-HPLC assay for combined olmesartan medoxomil and azelnidipine, indicating reliable stability testing with minimal environmental impact.
In the present study, a simple and selective high‐performance liquid chromatography (HPLC) method for Olmesartan Medoxomil (OLM) and Azelnidipine (AZL) was developed and subsequently validated by reverse‐phase LC. Separation was achieved on an Agilent ZORBAX C18 (150 mm × 4.6 mm, 5 µm) at Room temperature using 0.05 M ammonium formate buffer (pH 3.5) and methanol (30:70 %v/v) as the mobile phase in isocratic mode, and the chromatogram was developed at 262 nm. Under the optimized chromatographic conditions, the retention times of OLM and AZL were observed at 3.71 and 5.39 min, respectively. A strong linear detector response was obtained over concentration ranges of 10–30 µg/mL for OLM and 4–12 µg/mL for AZL, with correlation coefficient ( R 2 ) values of 0.999 for both analytes. The mean recovery of the accuracy study was between 99.33% and 101.43%, respectively. The results obtained for precision, limit of detection, limit of quantification, and robustness were within limits and validated under different stress conditions as per ICH guidelines. Both drugs exhibited susceptibility to degradation under acidic, basic, oxidative, photolytic, and thermal stress conditions. Forced degradation studies confirmed its reliability for drug analysis, and an Analytical Greenness outcome highlighted its environmental sustainability as compared to other reported methods.
No takes yet. Share an insight, caveat, or question.
Maru et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: